Researchers have developed a new technique that could allow liver transplant recipients to live without lifelong immunosuppressive drugs, potentially transforming outcomes for patients worldwide.
The breakthrough, reported by medical teams across the Middle East, involves a novel approach known as the BOOST technique, which has demonstrated the ability to significantly enhance liver function in transplanted organs—improving performance by up to 500% in preclinical models.
According to findings shared by scientists from institutions in Saudi Arabia, Qatar, and the United Arab Emirates, the method reprograms the body’s acceptance of the transplanted liver, reducing or eliminating the need for anti-rejection medications that patients typically must capture for life.
These drugs, while essential for preventing organ rejection, carry serious long-term risks, including increased susceptibility to infections, kidney damage, hypertension, and higher chances of developing diabetes or certain cancers.
By enabling the immune system to tolerate the new liver naturally, the BOOST technique aims to improve both survival rates and quality of life for transplant recipients, while also addressing global challenges related to organ shortages and long waiting lists.
Experts involved in the research said the approach could one day reduce reliance on lifelong pharmacotherapy after liver transplantation, marking a significant step toward inducing immune tolerance in solid organ transplants.
The development builds on years of investigation into regenerative medicine and immunomodulation, with early results showing promising signs of functional liver recovery and reduced inflammation post-transplant.
While the technique remains under study and has not yet been approved for widespread clinical use, researchers emphasized that continued progress could reshape standard care for liver transplant patients in the coming years.
For individuals awaiting transplants or living with donated livers, the prospect of fewer medications and fewer complications represents a meaningful advance in transplant medicine.
